Literature DB >> 27158981

Identification and comparison of the volatile constituents of fresh and dried leaves of Spondias mombin found in North-central Nigeria: in vitro evaluation of their cytotoxic and antioxidant activities.

Abdulkabir Oladele Oladimeji1,2, Medinat Bola Aliyu1, Akintayo Lanre Ogundajo3, Oluwatoyin Babatunde4, Oluremi Ishola Adeniran5, Olaoye Solomon Balogun6.   

Abstract

CONTEXT: Various studies have shown that the leaf extracts of Spondias mombin Linn (Anacardiaceae) possess pharmacological properties such as antioxidant and antiviral effects. However, no biological activity from its essential oil has been reported in literature.
OBJECTIVE: To analyse the chemical constituents, cytotoxic activity and antioxidant capability of the essential oils from fresh and dried leaves of S. mombin.
MATERIALS AND METHODS: Hydrodistillation using Clevenger-type apparatus was employed to obtain the essential oil. Oil analysis was performed using an HP 6890 Gas Chromatograph coupled with an HP 5973 Mass Selective Detector. The cytotoxicity bioassay was carried out using the brine shrimp lethality test (10,000-0.01 μg/mL). Additionally, the reactive oxygen species scavenging potential of the two S. mombin oils (1000-200 μg/mL) were investigated using a hydroxyl radical scavenging and ferric iron reducing system.
RESULTS: Chemical analysis of essential oils from S. mombin revealed the presence of 41 compounds, with predominance of monoterpenoids, sesquiterpenoids and non-terpenoids derivatives. In both fractions, the principal component was β-caryophellene (27.9-30.9%), followed by γ-cadinene (9.7-12.3%). There was an increase in the oxygenated monoterpenoid contents and a concomitant decrease in the amounts of sesquiterpenoids hydrocarbons observed on drying the leaves. The oil obtained from the fresh leaves was more active than that obtained from dried leaves, with LC50 values (from the brine shrimp lethality assay) of 0.01 and 4.78 μg/mL, respectively. The two oils (from fresh and dried leaves) at 1.0 mg/mL scavenged hydroxyl radical by 83% and 99.8%, respectively. Moreover, they reduced ferric ion significantly and compared favourably with vitamin C.
CONCLUSIONS: Essential oil derived from the leaves of S. mombin could hold promise for future application in the treatment of cancer-related diseases.

Entities:  

Keywords:  Anacardiaceae; brine shrimp lethality test; essential oils; phytochemical; β-caryophellene

Mesh:

Substances:

Year:  2016        PMID: 27158981     DOI: 10.1080/13880209.2016.1178308

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  3 in total

1.  Antiulcer Activity and Potential Mechanism of Action of the Leaves of Spondias mombin L.

Authors:  Samara Alves Brito; Cynthia Layse Ferreira de Almeida; Temístocles Italo de Santana; Alisson Rodrigo da Silva Oliveira; Jéssica Carla Bezerra do Nascimento Figueiredo; Isis Torres Souza; Lécio Leone de Almeida; Márcia Vanusa da Silva; Augusto Santos Borges; Jonathan Wagner de Medeiros; Jacinto da Costa Silva Neto; Rita de Cássia Ribeiro Gonçalves; Rodrigo Rezende Kitagawa; Antônio Euzébio Goulart Sant'Ana; Larissa Araújo Rolim; Irwin Rose Alencar de Menezes; Teresinha Gonçalves da Silva; Germana Freire Rocha Caldas; Almir Gonçalves Wanderley
Journal:  Oxid Med Cell Longev       Date:  2018-04-26       Impact factor: 6.543

Review 2.  A review on anti-peptic ulcer activities of medicinal plants used in the formulation of Enterica, Dyspepsia and NPK 500 capsules.

Authors:  Doris Kumadoh; Mary-Ann Archer; Genevieve N Yeboah; Michael O Kyene; Mavis Boakye-Yiadom; Ofosua Adi-Dako; Christina Osei-Asare; Emmanuel Adase; Alfred A Appiah; Susana O Mintah
Journal:  Heliyon       Date:  2021-11-29

3.  Essential Oils from the Fruits and Leaves of Spondias mombin Linn.: Chemical Composition, Biological Activity, and Molecular Docking Study.

Authors:  Gertrude Adomaa Asante Ampadu; Jehoshaphat Oppong Mensah; Godfred Darko; Lawrence Sheringham Borquaye
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-28       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.